Fosun International LTD Vertex Pharmaceuticals Inc Transaction History

Fosun International LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $613,560 - $727,440	-2,400 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$225.48 - $295.8 $270,576 - $354,960	-1,200 Reduced 33.33%	2,400 $684,000
Q1 2020 May 11, 2020	BUY	$199.77 - $247.81 $719,172 - $892,116	3,600 New	3,600 $835,000
Q1 2019 May 10, 2019	SELL	$163.73 - $194.7 $818,650 - $973,500	-5,000 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$167.73 - $192.74 $838,650 - $963,700	5,000 New	5,000 $949,000

1,725

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.